Diamond Hill Capital Management’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.3M Buy
544,034
+111,308
+26% +$2.64M 0.08% 120
2025
Q4
$10.7M Buy
432,726
+71,462
+20% +$1.9M 0.06% 127
2025
Q3
$10.2M Buy
361,264
+89,733
+33% +$2.43M 0.05% 127
2025
Q2
$6.76M Buy
271,531
+60,493
+29% +$1.7M 0.03% 133
2025
Q1
$6.54M Buy
211,038
+51,827
+33% +$1.73M 0.03% 127
2024
Q4
$5.02M Buy
159,211
+16,911
+12% +$803K 0.02% 137
2024
Q3
$8.24M Buy
142,300
+38,826
+38% +$1.91M 0.03% 129
2024
Q2
$4.2M Buy
+103,474
New +$4.1M 0.02% 140

Other funds holding ASTH

Diamond Hill Capital Management's ASTH Position: Q1 2026 in Review

Diamond Hill Capital Management increased its Astrana Health (ASTH) stake by 26% in Q1 2026, buying an estimated $2.64M and bringing the position to 544,034 shares worth $13.3M. The position accounts for 0.08% of the portfolio, ranked #120.

Diamond Hill Capital Management first reported a position in ASTH in Q2 2024 and has held it in 8 quarters since. 171 funds tracked by Wall St. Rank hold ASTH as of Q1 2026.

  • Diamond Hill Capital Management held 544,034 shares of Astrana Health worth $13.3M as of Q1 2026.
  • Diamond Hill Capital Management bought 111,308 Astrana Health shares in Q1 2026, an estimated $2.64M.
  • Astrana Health made up 0.08% of Diamond Hill Capital Management's portfolio in Q1 2026, its #120 holding.
  • Diamond Hill Capital Management first reported a position in Astrana Health in Q2 2024 and has held it in 8 quarters since.
  • 171 funds tracked by Wall St. Rank held Astrana Health as of Q1 2026.

Based on Diamond Hill Capital Management's 13F filing for Q1 2026, filed 7 May 2026.